re: nrt chart = wrong decision I think we could get $10 per share dividends or more should Phenoxodiol work and get approved.
Look at Gleevec which only treats a small proportion of leukemias. They are already getting $1bn in revenue from this drug. Considering Leukemia is a fairly rare cancer the potential market is massive.
All we need it to start the ball rolling. Either with the trials at RNS in leukemia or Yale for Ovarian. I believe it's currently being tested in prostate cancer patients (oral version). More trials are set to start soon.
I wish we could have weekly updates with these current trials but it's just a matter of time till we see the results.
Cheers,
Munch.
- Forums
- ASX - By Stock
- KZA
- nrt ..chart
nrt ..chart, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online